HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing in Brief: Parfums Lucien Lelong

This article was originally published in The Rose Sheet

Executive Summary

Parfums Lucien Lelong: Revamped Indiscret fragrance will feature an "updated" juice formulation from the original 1936 scent, the Engelwood Cliffs, N.J.-based company said. The relaunch will be supported with a "seductive" ad campaign carrying the tagline "For the other woman in you," Parfums Lucien Lelong said. Promotional activities will include "heavy" sampling at store-level and at charity functions, the company added. The enhanced "green fruity floral" opens with top notes of lemon, neroli and Italian bergamot, warms to a heart of basil, clove and violet and dries down to a mix of amber, oak moss and sandalwood. Rolling out to Bergdorf Goodman in mid-September, the five-SKU line includes a .25 oz limited edition crystal perfume collector's flacon priced at $250 and 1.7 oz. and 3.4 oz. eau de parfums at $65 and $90, respectively...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel